Peer-reviewed veterinary case report
Size Matters: Superior Efficacy of α Particle Radioimmunotherapy in Micrometastases versus Macrometastases.
- Journal:
- Clinical cancer research : an official journal of the American Association for Cancer Research
- Year:
- 2025
- Authors:
- Patel, Ravi B et al.
- Affiliation:
- Department of Radiation Oncology · United States
- Species:
- rodent
Abstract
Radiopharmaceuticals, which emit either α or β particles, have changed the landscape of prostate cancer imaging and treatment. Each particle type has unique physical properties that can be exploited to optimize treatment effect. Using murine models of disseminated prostate cancer and a CD46-targeted α particle-emitting radioimmunoconjugate, a recent study shows superior efficacy in mice bearing micrometastastic versus macrometastatic disease. See related article by Bidkar et al., p. 2963.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/40366383/